GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (CHIX:FREd) » Definitions » EV-to-Revenue

Fresenius SE KGaA (CHIX:FRED) EV-to-Revenue : 1.32 (As of Oct. 31, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Fresenius SE KGaA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Fresenius SE KGaA's enterprise value is €29,606 Mil. Fresenius SE KGaA's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €22,360 Mil. Therefore, Fresenius SE KGaA's EV-to-Revenue for today is 1.32.

The historical rank and industry rank for Fresenius SE KGaA's EV-to-Revenue or its related term are showing as below:

CHIX:FREd' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.25   Med: 1.78   Max: 2.49
Current: 1.33

During the past 13 years, the highest EV-to-Revenue of Fresenius SE KGaA was 2.49. The lowest was 1.25. And the median was 1.78.

CHIX:FREd's EV-to-Revenue is ranked better than
60.97% of 661 companies
in the Healthcare Providers & Services industry
Industry Median: 1.76 vs CHIX:FREd: 1.33

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-10-31), Fresenius SE KGaA's stock price is €33.54. Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €39.66. Therefore, Fresenius SE KGaA's PS Ratio for today is 0.85.


Fresenius SE KGaA EV-to-Revenue Historical Data

The historical data trend for Fresenius SE KGaA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA EV-to-Revenue Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.79 1.49 1.45 2.40 1.35

Fresenius SE KGaA Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 1.86 1.35 1.28 1.21

Competitive Comparison of Fresenius SE KGaA's EV-to-Revenue

For the Medical Care Facilities subindustry, Fresenius SE KGaA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's EV-to-Revenue falls into.



Fresenius SE KGaA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Fresenius SE KGaA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=29605.639/22360
=1.32

Fresenius SE KGaA's current Enterprise Value is €29,606 Mil.
Fresenius SE KGaA's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €22,360 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA  (CHIX:FREd) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Fresenius SE KGaA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=33.54/39.655
=0.85

Fresenius SE KGaA's share price for today is €33.54.
Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €39.66.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA Headlines

No Headlines